KTOV up 26% @ .72 > Orbimed Advisors LLC Acquires Shares of 3,461,983 KITOV PHARMA LT/S (NASDAQ:KTOV)
Posted by Amelie Mason on Jun 21st, 2020
KITOV PHARMA LT/S logoOrbimed Advisors LLC acquired a new stake in KITOV PHARMA LT/S (NASDAQ:KTOV) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 3,461,983 shares of the company’s stock, valued at approximately $1,058,000. Orbimed Advisors LLC owned 8.58% of KITOV PHARMA LT/S at the end of the most recent reporting period.
Separately, Morgan Stanley raised its stake in shares of KITOV PHARMA LT/S by 718.5% during the 1st quarter. Morgan Stanley now owns 558,727 shares of the company’s stock worth $171,000 after acquiring an additional 490,462 shares in the last quarter. 7.44% of the stock is owned by institutional investors and hedge funds.
Several research firms recently commented on KTOV. Zacks Investment Research lowered shares of KITOV PHARMA LT/S from a “buy” rating to a “hold” rating in a research note on Friday, May 8th. ValuEngine upgraded shares of KITOV PHARMA LT/S from a “hold” rating to a “buy” rating in a research note on Thursday, March 5th.
NASDAQ:KTOV traded up $0.09 during trading hours on Friday, hitting $0.57. 41,463,656 shares of the company were exchanged, compared to its average volume of 8,302,089. The stock has a market capitalization of $54.37 million, a price-to-earnings ratio of -1.90 and a beta of 3.11. KITOV PHARMA LT/S has a 52-week low of $0.22 and a 52-week high of $1.08. The company’s 50 day moving average price is $0.47 and its 200-day moving average price is $0.56.
News 
Market Data 
Discover 
AI
